Skip to main content
Beximco Pharmaceuticals Ltd. logo

Beximco Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · BXP ISIN · US0885792061 LEI · 213800IMBBD6TIOQGB56 IL Manufacturing
Open in API
Filings indexed 125 across all filing types
Latest filing 2023-01-30 Interim / Quarterly Rep…
Country BD Bangladesh
Listing IL BXP

About Beximco Pharmaceuticals Ltd.

https://www.beximcopharma.com

Beximco Pharmaceuticals Ltd. is a manufacturer of generic drugs and active pharmaceutical ingredients (APIs). The company produces a broad portfolio of over 500 products across various therapeutic categories, with a focus on providing access to affordable medicines. It has established a strong market differentiation through a range of high-tech, specialized products, including metered-dose and dry powder inhalers. Serving numerous emerging and developed markets globally, its manufacturing facilities are accredited by major international regulatory authorities, including those of the USA, European Union, Australia, and Canada.

Recent filings

Filing Released Lang Actions
Half Year Results 2022-23
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Half Year Results 2022-23' for Beximco Pharmaceuticals Limited. It contains comprehensive unaudited financial statements, including the Consolidated Statement of Financial Position, Statement of Profit or Loss and Other Comprehensive Income, Statement of Changes in Equity, and Statement of Cash Flows for the six-month period ended December 31, 2022. As it provides substantive financial data for an interim period, it is classified as an Interim/Quarterly Report. H1 2022
2023-01-30 English
Payment of Cash Dividend
Notice of Dividend Amount Classification · 1% confidence The document is an official announcement from Beximco Pharmaceuticals regarding the payment of a cash dividend to GDR holders. It specifies the dividend amount (35% or Taka 3.50 per share), the reference period (year ended 30 June 2022), and the confirmation that funds have been deposited with the custodian bank. This fits the definition of a 'Notice of Dividend Amount' (DIV).
2023-01-19 English
Annual General Meeting Statement
AGM Information Classification · 1% confidence The document is an RNS announcement from Beximco Pharmaceuticals Limited regarding the results of their Annual General Meeting (AGM). It explicitly states that all resolutions were passed, including the approval of a cash dividend. While it mentions the Annual Report, it is not the report itself, but rather a notification of the meeting outcome and dividend declaration. Given the primary focus on the voting results of the AGM, 'DVA' (Declaration of Voting Results) is the most accurate classification.
2022-12-23 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is a short notification from the London Stock Exchange's RNS (Regulatory News Service) regarding a 'Second Price Monitoring Extension' for Beximco Pharmaceuticals Ltd. It is a standard automated regulatory announcement concerning trading mechanics rather than a financial report, management update, or corporate action. As it does not fit into specific categories like M&A, dividends, or share issues, it falls under the general regulatory filing category.
2022-11-29 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is a short notification from the London Stock Exchange's Regulatory News Service (RNS) regarding a 'Price Monitoring Extension' for Beximco Pharmaceuticals Ltd. It is a standard automated regulatory notice concerning trading parameters rather than a financial report, management update, or corporate action. As it does not fit into specific categories like M&A, dividends, or share issues, it falls under the general regulatory filing category.
2022-11-29 English
AGM Notification
AGM Information Classification · 1% confidence The document is an official announcement from Beximco Pharmaceuticals regarding the scheduling and agenda of their upcoming Annual General Meeting (AGM). It outlines the business to be transacted, such as the adoption of financial statements, dividend declaration, and election of directors. While it mentions the Annual Report, it is not the report itself, but rather the notification of the meeting. Therefore, it falls under the category of AGM Information.
2022-11-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.